Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Universidad De Concepción has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution is concentrated in 1 distinct examiner and a distinct art unit. This singular focus suggests that the university is currently advancing a specific patent application or a very narrow technological innovation. By focusing on a single art unit, the applicant can better navigate the specific technical standards prevalent in that area of Biotechnology & Pharmaceuticals. This concentrated approach is often efficient for academic institutions focusing on a core discovery.
CAIN, JENNIFER LYNN is the busiest examiner, holding 1 pending office action. This examiner is responsible for the entirety of the university's pending actions. Because the active workload is limited to 1 pending office action, the applicant can dedicate resources to addressing the specific feedback from this examiner. The involvement of a single art unit simplifies the administrative tracking of the current portfolio. With 1 pending office action assigned to CAIN, JENNIFER LYNN, the university's patenting success in this cycle is directly tied to the resolution of this single matter. This allows for a highly focused and potentially more effective response to the patent office's requirements.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CAIN, JENNIFER LYNN | 1 | 43.5% | +67.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17758045 | ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF DURVILLAEA ANTARCTICA USEFUL FOR TREATING LESIONS CAUSED BY ALPHAHERPESVIRINAE VIRUS | CAIN, JENNIFER LYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17758045 | ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF DURVILLAEA ANTARCTICA USEFUL FOR TREATING LESIONS CAUSED BY ALPHAHERPESVIRINAE VIRUS | CAIN, JENNIFER LYNN | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17758045 | ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF DURVILLAEA ANTARCTICA USEFUL FOR TREATING LESIONS CAUSED BY ALPHAHERPESVIRINAE VIRUS | CAIN, JENNIFER LYNN | 1655 | §101§103§112 | Final Rejection | — | Pending | Jun 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversidad De Concepción has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jennifer Lynn Cain has the most, with 1 of Universidad De Concepción's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
